Evidence map›Paper›PMID 40150706›Full record

ArticleBioengineering (Basel, Switzerland)2025

Simplatab: An Automated Machine Learning Framework for Radiomics-Based Bi-Parametric MRI Detection of Clinically Significant Prostate Cancer.

Dimitrios I Zaridis, Vasileios C Pezoulas, Eugenia Mylona, Charalampos N Kalantzopoulos, Nikolaos S Tachos, Nikos Tsiknakis, George K Matsopoulos, Daniele Regge, Nikolaos Papanikolaou, Manolis Tsiknakis and 2 more

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Dimitrios I ZaridisBiomedical Research Institute, FORTH, GR 45110 Ioannina, Greece.
Vasileios C PezoulasUnit of Medical Technology Intelligent Information Systems, University of Ioannina, GR 45110 Ioannina, Greece.
Eugenia MylonaBiomedical Research Institute, FORTH, GR 45110 Ioannina, Greece.ORCID 0000-0002-1275-6249
Charalampos N KalantzopoulosBiomedical Research Institute, FORTH, GR 45110 Ioannina, Greece.
Nikolaos S TachosBiomedical Research Institute, FORTH, GR 45110 Ioannina, Greece.ORCID 0000-0002-8627-6352
Nikos TsiknakisInstitute of Computer Science, FORTH, GR 70013 Heraklion, Greece.ORCID 0000-0002-7581-467X
George K MatsopoulosBiomedical Engineering Laboratory, School of Electrical and Computer Engineering, National Technical University of Athens, GR 15780 Athens, Greece.ORCID 0000-0002-2600-9914
Daniele ReggeDepartment of Radiology, Candiolo Cancer Institute, FPO-Istituto di Ricovero e Cura a Carattere Scientifico, Strada Provinciale 142 Km 3.95, IT 10060 Candiolo, Turin, Italy.ORCID 0000-0001-8267-5279
Nikolaos PapanikolaouComputational Clinical Imaging Group, Champalimaud Foundation, PT 1400-038 Lisboa, Portugal.ORCID 0000-0003-3298-2072
Manolis TsiknakisComputational Biomedicine Laboratory, Institute of Computer Science, FORTH, GR 70013 Heraklion, Greece.ORCID 0000-0001-8454-1450
Kostas MariasComputational Biomedicine Laboratory, Institute of Computer Science, FORTH, GR 70013 Heraklion, Greece.ORCID 0000-0003-3783-5223
Dimitrios I FotiadisBiomedical Research Institute, FORTH, GR 45110 Ioannina, Greece.ORCID 0000-0002-7362-5082

Funding

European Commision, funded under SOCIETAL CHALLENGES - Health, demographic change and well-being 952159
6 · The paper itself

Abstract

backgroundProstate cancer (PCa) diagnosis using MRI is often challenged by lesion variability.

methodsThis study introduces Simplatab, an open-source automated machine learning (AutoML) framework designed for, but not limited to, automating the entire machine Learning pipeline to facilitate the detection of clinically significant prostate cancer (csPCa) using radiomics features. Unlike existing AutoML tools such as Auto-WEKA, Auto-Sklearn, ML-Plan, ATM, Google AutoML, and TPOT, Simplatab offers a comprehensive, user-friendly framework that integrates data bias detection, feature selection, model training with hyperparameter optimization, explainable AI (XAI) analysis, and post-training model vulnerabilities detection. Simplatab requires no coding expertise, provides detailed performance reports, and includes robust data bias detection, making it particularly suitable for clinical applications.

resultsEvaluated on a large pan-European cohort of 4816 patients from 12 clinical centers, Simplatab supports multiple machine learning algorithms. The most notable features that differentiate Simplatab include ease of use, a user interface accessible to those with no coding experience, comprehensive reporting, XAI integration, and thorough bias assessment, all provided in a human-understandable format.

conclusionsOur findings indicate that Simplatab can significantly enhance the usability, accountability, and explainability of machine learning in clinical settings, thereby increasing trust and accessibility for AI non-experts.

Indexed as

artificial intelligenceautomated machine learning frameworkAutoMLMRIopen sourceprostate cancerradiomics

Identifiers

PMID40150706
PMCPMC11939345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.